Posted inStock
Catalent to sell New Jersey facility
(Reuters) – Catalent (NYSE:CTLT) has agreed to sell its oral drug development and small-scale manufacturing facility in Somerset, New Jersey to private contract drug manufacturer Ardena, the companies said on…